TET2 and B-cell chronic lymphocytic leukemia: In this study, we aimed to gain a deeper understanding of TOX compared to TOX2 in human CD4+ and CD8+ CAR T cells, prompted by our observation of chromatin opening at both genes in the patient with CLL with disrupted TET2.